{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:32:55Z","timestamp":1791567175301,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009561","name":"American Partnership for Eosinophilic Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.anai.2021.08.013","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T03:09:46Z","timestamp":1628824186000},"page":"597-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnoses associated with peripheral blood eosinophilia"],"prefix":"10.1016","volume":"127","author":[{"given":"Nicholas","family":"Leverone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Akuthota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2021.08.013_bib0001","series-title":"Eosinophils in Health and Disease","first-page":"277","article-title":"Eosinophils and anti-pathogen host defense","author":"Gleich","year":"2012"},{"issue":"2","key":"10.1016\/j.anai.2021.08.013_bib0002","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.seminhematol.2012.01.005","article-title":"Eosinophils and disease pathogenesis","volume":"49","author":"Akuthota","year":"2012","journal-title":"Semin Hematol"},{"issue":"2","key":"10.1016\/j.anai.2021.08.013_bib0003","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jaci.2017.09.022","article-title":"Eosinophils and eosinophil-associated diseases: an update","volume":"141","author":"O'Sullivan","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.anai.2021.08.013_bib0004","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaip.2019.11.024","article-title":"Eosinophilia asthma","volume":"8","author":"Nelson","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"20","key":"10.1016\/j.anai.2021.08.013_bib0005","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anai.2021.08.013_bib0006","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jaci.2020.08.037","article-title":"Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial","volume":"146","author":"Roufosse","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.anai.2021.08.013_bib0007","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1016\/j.jaip.2019.05.011","article-title":"Pediatric hypereosinophilia: characteristics, clinical manifestations, and diagnoses","volume":"7","author":"Burris","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.anai.2021.08.013_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2010.01.055","article-title":"Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract","volume":"126","author":"Simon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2021.08.013_bib0009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/JLB.5MR0118-028R","article-title":"Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD)","volume":"104","author":"Khoury","year":"2018","journal-title":"J Leukoc Biol"},{"issue":"1","key":"10.1016\/j.anai.2021.08.013_bib0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaci.2010.04.011","article-title":"Practical approach to the patient with hypereosinophilia","volume":"126","author":"Roufosse","year":"2010","journal-title":"J Allergy Clin Immunol"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621005718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120621005718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:27:04Z","timestamp":1761053224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120621005718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1081120621005718"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2021.08.013","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnoses associated with peripheral blood eosinophilia","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2021.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}